Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects

被引:43
|
作者
Terao, T [1 ]
Yoshimura, R [1 ]
Ohmori, O [1 ]
Takano, T [1 ]
Takahashi, N [1 ]
Iwata, N [1 ]
Suzuki, T [1 ]
Abe, K [1 ]
机构
[1] UNIV OCCUPAT & ENVIRONM HLTH,DEPT ERGON,YAHATANISHI KU,KITAKYUSHU,FUKUOKA 807,JAPAN
关键词
cholesterol; serotonin; meta-chlorophenylpiperazine; cortisol; adrenocorticotropic hormone; prolactin;
D O I
10.1016/S0006-3223(96)00213-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
This study was undertaken to test the hypothesis that serum cholesterol levels might be associated with serotonergic receptor function, The participants were 10 healthy male subjects. After an overnight fast, the subjects received meta-chlorophenylpiperazine (m-CPP) or identical placebo capsules orally in a randomized double-blind, cross-over design. Blood was obtained for measurement of prolactin, cortisol, adrenocorticotropic hormone (ACTH), and cholesterol. There were some significantly positive correlations between serum cholesterol levels and hormonal responses to m-CPP administration, These results suggest that serum cholesterol levels may be positively associated with serotonergic receptor function. (C) 1997 Society of Biological Psychiatry.
引用
收藏
页码:974 / 978
页数:5
相关论文
共 50 条
  • [1] Relationship between serum cholesterol levels and meta-chlorophenylpiperazine-induced cortisol responses in healthy men and women
    Terao, T
    Nakamura, J
    Yoshimura, R
    Ohmori, O
    Takahashi, N
    Kojima, H
    Soeda, S
    Shinkai, T
    Nakano, H
    Okuno, T
    PSYCHIATRY RESEARCH, 2000, 96 (02) : 167 - 173
  • [2] Effect of aerobic exercise on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine and to ipsapirone in untrained healthy subjects
    Broocks, A
    Meyer, T
    Gleiter, CH
    Hillmer-Vogel, U
    George, A
    Bartmann, U
    Bandelow, B
    PSYCHOPHARMACOLOGY, 2001, 155 (03) : 234 - 241
  • [3] PITUITARY-HORMONE RESPONSES TO META-CHLOROPHENYLPIPERAZINE IN PANIC DISORDER AND HEALTHY CONTROL SUBJECTS
    KAHN, RS
    WETZLER, S
    ASNIS, GM
    KLING, MA
    SUCKOW, RF
    VANPRAAG, HM
    PSYCHIATRY RESEARCH, 1991, 37 (01) : 25 - 34
  • [4] EFFECTS OF RITANSERIN ON THE BEHAVIORAL, NEUROENDOCRINE, AND CARDIOVASCULAR-RESPONSES TO META-CHLOROPHENYLPIPERAZINE IN HEALTHY-HUMAN SUBJECTS
    SEIBYL, JP
    KRYSTAL, JH
    PRICE, LH
    WOODS, SW
    DAMICO, C
    HENINGER, GR
    CHARNEY, DS
    PSYCHIATRY RESEARCH, 1991, 38 (03) : 227 - 236
  • [5] Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers
    Maes, M
    Meltzer, HY
    PSYCHIATRY RESEARCH, 1996, 64 (03) : 147 - 159
  • [6] Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment
    Broocks, A
    Briggs, NC
    Pigott, TA
    Hill, JL
    Canter, SK
    Tolliver, TJ
    Baldemore, D
    Murphy, DL
    PSYCHOPHARMACOLOGY, 1997, 130 (02) : 91 - 103
  • [7] Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment
    A. Broocks
    Nathaniel C. Briggs
    Teresa A. Pigott
    James L. Hill
    Stephanie K. Canter
    Teresa J. Tolliver
    Deborah Baldemore
    D. L. Murphy
    Psychopharmacology, 1997, 130 : 91 - 103
  • [8] EFFECTS OF SEROTONIN ANTAGONISTS ON META-CHLOROPHENYLPIPERAZINE-MEDIATED RESPONSES IN NORMAL SUBJECTS
    KAHN, RS
    KALUS, O
    WETZLER, S
    CAHN, W
    ASNIS, GM
    VANPRAAG, HM
    PSYCHIATRY RESEARCH, 1990, 33 (02) : 189 - 198
  • [9] EFFECTS OF CHRONIC FLUOXETINE TREATMENT ON BEHAVIORAL AND NEUROENDOCRINE RESPONSES TO META-CHLOROPHENYLPIPERAZINE IN OBSESSIVE-COMPULSIVE DISORDER
    HOLLANDER, E
    DECARIA, C
    GULLY, R
    NITESCU, A
    SUCKOW, RF
    GORMAN, JM
    KLEIN, DF
    LIEBOWITZ, MR
    PSYCHIATRY RESEARCH, 1991, 36 (01) : 1 - 17
  • [10] Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers
    Sabbe, B
    Hulstijn, W
    Maes, M
    Pier, M
    Scharpé, S
    Zitman, F
    PSYCHIATRY RESEARCH, 2001, 105 (03) : 151 - 163